Behind the Money

This week's episode of Behind The Money will be available on Wednesday morning, instead of our usual time on Tuesday. Be sure to check back Wednesday morning for a brand episode. Hosted on Acast. See acast.com/privacy for more information.

Private equity has flooded the deal market in recent years, in part due to an era of cheap debt and fund managers on the hunt for greater investment returns. Firms are scooping up stakes in oil pipelines and newspapers — and even dental clinics. With a record $1.8tn in pension and sovereign wealth fund money waiting to be invested, some analysts are asking when private equity’s winning run will come to an end. With the FT's Javier Espinoza. Read more here. Review clips: CNBC, NBC, Bloomberg. Hosted on Acast. See acast.com/privacy for more information.

The Canadian company was the first cannabis producer to make an initial public offering on a US stock exchange, and, after a week of volatile trading, some analysts are asking if investor excitement has gotten ahead of reality. The FT's Nicole Bullock explains.Review clips: Fox Business Network, ABC, CBS, BNN Bloomberg, CNBC, Bloomberg. Music by Podington Bear. Hosted on Acast. See acast.com/privacy for more information.

Nick was a regulator at the London Stock Exchange. Julia was an entrepreneur whose home was foreclosed. Ten years on from the collapse of Lehman Brothers we talk to two people with different perspectives on the lessons of the global financial crisis.Review clips: AP, CBS. Hosted on Acast. See acast.com/privacy for more information.

The name “Sackler” adorns museums and art galleries around the world. But the family name has also become tainted by its association with the US opioid crisis, amid accusations that OxyContin, more than any other drug, is responsible for sparking one of the worst public health epidemics of modern times. The FT's David Crow explains how the Sackler family company Purdue Pharma got its hold on the opioid market.   Hosted on Acast. See acast.com/privacy for more information.

Medical marijuana is legal in 21 countries. In Canada, residents expect they will be able to buy cannabis from dispensaries and pharmacies across the country later this year. Some analysts have valued the legal business at anywhere between $7bn-$20bn, attracting a host of entrepreneurs and investors trying to get in on the action before the market takes off. We talk to two entrepreneurs with two very different plans to capitalise on the boom. This episode was originally published on June 12, 2018. Read more about the cannabis sector on FT.com.  Hosted on Acast. See acast.com/privacy for more information.

A little more than a year ago, Uber's board was in search of a new chief executive. Co-founder Travis Kalanick had resigned from the top job amid allegations of a toxic and sexist company culture, and the board was looking for someone to fix the group's operations and ready it for what is expected to be the tech world's biggest public offering. Behind The Money looks at Dara Khosrowshahi's first year at the helm. With the FT's Shannon Bond. Review clips: ABC News, WSJ, NBC News, CBS News, CNBC, Fox Business Network Hosted on Acast. See acast.com/privacy for more information.

The amount of outstanding student debt in the US has hit a staggering $1.4tn, and many millennials say the education-related debt they've been saddled with has prevented them from doing things like buying a home, getting married and taking career risks. Who has been hit the hardest by student debt loads and what does it mean for the US economy? With guests Michael Ranalli, Judith Scott-Clayton and the FT's Sam Fleming. Read more of Sam's reporting at FT.com.Review clips: Fox Business Network, CBS News, CNBC Hosted on Acast. See acast.com/privacy for more information.

What is behind Elon Musk's plan to take the electric carmaker private, and who will provide the funding? The FT's Arash Massoudi explains the story that has unfolded since the chief executive posted his "funding secured" tweet. Read more here. Review clips: CityTV, CNBC, MSNBC, Bloomberg.  Hosted on Acast. See acast.com/privacy for more information.

Elon Musk's grand vision for the electric carmaker has drawn dedicated fans and followers. But Tesla has also tested the patience of customers and investors after a hit-and-miss on production targets while burning through cash. What will it take for Tesla to become a stable and profitable car manufacturer? The FT’s Richard Waters examines its prospects. Read more here.  Hosted on Acast. See acast.com/privacy for more information.